{
    "2021-11-19": [
        [
            {
                "time": "",
                "original_text": "智飞生物：取得重组新冠疫苗Ⅲ期临床试验关键性数据",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠疫苗",
                        "Ⅲ期临床试验",
                        "关键性数据"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物接受140家机构调研！短期主力资金净流入，市场资金或早已察觉",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "机构调研",
                        "主力资金净流入",
                        "市场资金"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：公司于去年参与深圳深信生物科技有限公司融资，该公司是一家主要从事mRNA技术研发和药品研究开发的生物企业",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "深圳深信生物",
                        "mRNA技术",
                        "融资"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "mRNA技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物：目前己取得重组新冠疫苗Ⅲ期临床试验关键性数据，结果显示出具有很好的安全性和防病效果",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "重组新冠疫苗",
                        "Ⅲ期临床试验",
                        "安全性",
                        "防病效果"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}